Indivior (INDV)

Healthcare · Drug Manufacturers - Specialty & Generic
$35.83 +1.07% on the day Market cap $4.1B 52-week range $22.95 to $42.81 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Indivior's free cash flow was negative in fiscal 2025, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

C

Five factors scored 1 to 9 from INDV's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability9
Growth7
Financial health1
Cash efficiency0

Results from SEC filings

Fiscal years, from Indivior's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$791M$901M$1.1B$1.2B$1.2B
Net income$205M-$42M-$126M$7M$210M
Free cash flow$319M-$9M-$308M$7M-$93M
EPS (diluted)$1.35-$0.30-$0.92$0.05$1.64
Operating margin26.9%-8.5%-13.9%3.2%21.1%

Where the revenue comes from

Revenue by products, fiscal 2023. Every breakdown, year by year.

SUBLOCADE$630M58%
Sublingual/Other$421M39%
PERSERIS$42M4%

Superinvestors who own INDV

From each investor's latest 13F filing (what a 13F shows). 3 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Howard Marks
Oaktree Capital Management
Trimmed $251M4.4%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed $9M0.00%Q2 2026
Joel Greenblatt
Gotham Asset Management
New position $4M0.01%Q2 2026

Insider buying

Open-market purchases by Indivior's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.

DateInsiderSharesPriceValue
Mar 9, 2026 Barbara Ryan
31$32.56$1,009
Mar 6, 2026 Stuart A Kingsley
940$31.86$29,948
Jan 5, 2026 Daniel A Ninivaggi
775$35.39$27,427
Jan 5, 2026 Keith Humphreys
775$35.39$27,427
Jan 5, 2026 Mark Stejbach
775$35.39$27,427
Jan 5, 2026 David E Wheadon
1,771$35.39$62,676
Jan 5, 2026 Barbara Ryan
775$35.39$27,427

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when INDV trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Indivior insiders buying the stock?

7 open-market insider purchases of INDV in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Indivior?

3 of the superinvestors Investingly tracks hold INDV in their latest 13F, including Howard Marks, Cliff Asness, Joel Greenblatt.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.